How Modeling & Simulation is Addressing the Immunogenicity Challenge: An academic nicety is now a drug development and regulatory differentiator
Learn how modeling and simulation can help drug developers overcome the immunogenicity challenge, a major…
Piet van der Graaf and Andrzej Kierzek2023 年 1 月 30 日
